However, the significance of PLK-1 in the pathogenesis and manage

However, the significance of PLK-1 in the pathogenesis and management of cervical carcinoma is not well-understood. In the present study, we demonstrated, for the first time, that PLK-1 is expressed in cervical carcinoma with a positive rate of 88.9%, and PLK-1 expression in tumors was associated with primary tumor progression (T stage). Interestingly, we found four samples that were negative for PLK-1 staining, which were later

found to be the differentiated samples. These results suggest that PLK-1 expression might be associated with the inactivity of cell mitosis. Therefore, our results indicate that PLK-1 may be a potential target for tumor evaluation and management of cervical carcinoma. PLK is a well-conserved family that has four known members in humans: PLK1, PLK2, PLK3, and PLK4 [10]. PLK1 expression is regulated during Z-IETD-FMK nmr cell cycle progression. Levels are low in G0, G1, and S, but begin to increase in G2 and peak in M phase. PLK-1 has attracted much attention in the field of carcinogenesis and cancer therapy due to its known functions. Blocking PLK-1 through RNA interference has shown promise as a way to intervene in cancer progression [18, 19]. RNA interference is a CP-690550 order newly discovered cellular pathway for silencing genes in a sequence-specific manner at the mRNA level through the introduction

of cognate double-stranded small interfering RNA (siRNA). This method is significantly more efficient than traditional Sinomenine antisense approaches. In

our previous study [4], we knocked down PLK-1 production in pancreatic cancer cells by utilizing siRNA transfection, and observed enhanced chemosensitivity to therapeutic agents. To further understand the importance of PLK-1 in the management of cervical carcinoma, we used siRNA transfection to knock down PLK-1 production in HeLa cells. It has been demonstrated that PLK-1 mRNA expression is elevated in proliferating cells, such as various cancer cell lines and tumors of different origins. Here, we observed the expression of PLK-1 mRNA in HeLa cells. We then transfected PLK-1 plasmids and PLK-1 siRNA into HeLa cells, to evaluate the effects of PLK-1 up- or LY2835219 molecular weight down-regulation on the biological characteristics of HeLa cells. As we expected, PLK-1 mRNA was significantly elevated after PLK-1 transfection, compared to the control cells transfected with empty plasmid. In contrast, PLK-1 siRNA significantly inhibited PLK-1 production in HeLa cells. These results showed that siRNA transfection of HeLa cells is able to knock down the expression of PLK-1. Based on these findings, we then performed morphological examinations to evaluate the functional consequences of PLK-1 knock-down on HeLa cell survival. We observed enhanced apoptosis in HeLa cells after PLK-1 knock-down with or without cisplatin treatment, as indicated by typical nuclear condensation and cellular shrinkage visualized by Hoechst staining.

Related posts:

  1. utations from the Smad4 gene in other tumor types are much less r
  2. Additionally, the two FITC labeled PIPs have been existing in all
  3. Indeed, we did not confirm a statistical enrichment for Bim expre
  4. The significance of this observation is unknown since no data are
  5. Effects Effects of EGFR-specific siRNA on target expression and m
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>